Tianeptine, Kratom and Gas-Station Drugs: What Georgians Should Know

Gas-station drugs are among the stranger features of the current addiction landscape: products sold openly, often within feet of energy drinks and beef jerky, that carry opioid-like dependence, acute withdrawal, and overdose risk. Tianeptine is the most clinically documented of these—an antidepressant used legitimately in some countries, repurposed and sold as an unregulated supplement in the United States under names like Neptune’s Fix and ZaZa. In Georgia, where it has been sold widely, tianeptine has produced hospitalizations, severe withdrawal presentations, and a growing number of patients in treatment who didn’t know they were using an opioid-active compound when they started. This is what Georgians need to know.

What Tianeptine Is and How It Works

Tianeptine is a tricyclic compound developed as an antidepressant and legally prescribed in France, Russia, and a number of other countries. Its antidepressant mechanism is debated, but at the doses used recreationally—far above therapeutic antidepressant doses—tianeptine acts as a mu-opioid receptor agonist, producing effects that users describe as similar to short-acting opioids: euphoria, sedation, anxiolysis, and analgesia. The duration of action is short (one to three hours for the sodium salt form), which drives frequent redosing and rapid escalation. Users who begin with one to three tablets per session routinely escalate to dozens per day as tolerance develops. The sulfate form, found in some products, has a slower onset and longer duration—reducing the acute rush but sustaining the dose escalation pattern. Because tianeptine is not federally classified as a controlled substance in the US, it has been sold as a dietary supplement, exempt from FDA oversight that would apply to a drug, and available without prescription in stores and online.

Why Tianeptine Is Dangerous: Dependence, Overdose, and Withdrawal

Tianeptine’s risk profile is substantially higher than typical dietary supplements and roughly comparable to prescription opioids in its dependence-producing potential. Physical dependence develops quickly—sometimes within days of regular use at elevated doses. Dose escalation is typical: the short half-life and rapid tolerance build create a compulsion to redose that users describe as more demanding than many prescription opioids. Overdose is possible and presents like opioid overdose—respiratory depression, loss of consciousness, pinpoint pupils—and responds to naloxone, confirming the opioid mechanism. The FDA issued warnings about tianeptine-containing products after receiving reports of serious adverse events, hospitalizations, and deaths. Withdrawal is severe and opioid-like: abrupt discontinuation after dependence produces the full opioid withdrawal syndrome—agitation, muscle aching, sweating, diarrhea, insomnia, and intense craving—beginning within hours of the last dose and lasting several days to more than a week depending on dose history. The withdrawal severity makes at-home discontinuation after heavy use dangerous and virtually always unsuccessful without medical support.

Kratom and the Broader Gas-Station Drug Category

Tianeptine sits alongside kratom as the two most clinically consequential gas-station opioid-active compounds in Georgia. Kratom (Mitragyna speciosa) contains mitragynine and 7-hydroxymitragynine, both of which bind opioid receptors—7-OH-mitragynine with particularly high potency. Like tianeptine, kratom is sold as a supplement, not regulated as a drug, and produces physical dependence with prolonged use. The two compounds are pharmacologically distinct but clinically similar in what they produce: patients who present in withdrawal who identify only as “kratom users” or “tianeptine users” rather than “opioid addicts” require opioid-withdrawal management regardless of the label they carry. The gas-station framing—legal, available, supplement-labeled—creates a false safety signal that delays treatment seeking. Families should understand that the legal status and retail availability of these products do not indicate low risk; they indicate a regulatory gap, not a clinical one.

What Tianeptine Withdrawal Looks Like—and How to Treat It

Tianeptine withdrawal presents as opioid withdrawal, which is its correct clinical framing. Onset is rapid—within hours of the last dose in heavy users—and the syndrome includes anxiety, agitation, diaphoresis, myalgia, gastrointestinal cramping, nausea, vomiting, diarrhea, insomnia, and overwhelming craving. Severity is dose-dependent: a person taking therapeutic-range doses who tapers gradually may experience relatively mild discontinuation discomfort; someone taking dozens of tablets per day faces a severe withdrawal that is extremely difficult to endure without medical support. Clinically, tianeptine withdrawal is managed similarly to opioid withdrawal: buprenorphine has been used for both stabilization and taper given the mu-opioid mechanism, with case reports supporting its effectiveness. Symptomatic medications—clonidine for autonomic symptoms, anti-diarrheals, sleep support—add comfort. The practical lesson: medically supervised detox is appropriate for tianeptine dependence, not an overreaction. Attempting to stop at home after significant dose escalation typically fails and unnecessarily prolongs suffering.

Treatment for Tianeptine and Gas-Station Drug Addiction

Treatment for tianeptine dependence follows the addiction medicine pathway used for opioid use disorder. Medical detox manages the acute withdrawal safely and reduces the biological barrier to stopping. Medication-assisted treatment—buprenorphine or naltrexone—addresses ongoing craving and reduces relapse risk after withdrawal resolves, exactly as it does in traditional opioid use disorder. Behavioral treatment—individual therapy, group, and relapse prevention planning—addresses the psychological drivers of use. Many patients with tianeptine dependence have underlying anxiety, depression, or chronic pain that the compound was addressing, however inadequately; those co-occurring conditions require parallel treatment, not afterthought. The clinical case for treating tianeptine as the opioid-mechanism disorder it is—not as a supplement problem that doesn’t warrant real treatment—is now well established in the addiction medicine literature. If you or someone in your family has been using tianeptine, ZaZa, Neptune’s Fix, or similar products and is concerned about dependence, call (678) 904-8617—the conversation is confidential, the assessment is clinical, and the treatment is the same evidence-based approach that works for opioid use disorder, because pharmacologically that is what this is.

Frequently Asked Questions

Is tianeptine legal in Georgia?

As of the time of publication, tianeptine is not federally scheduled as a controlled substance in the United States, though several individual states have banned it. Georgia law and any updates to federal scheduling should be confirmed through current state pharmacy board or DEA resources. Legal status does not indicate safety—tianeptine is physically addictive and carries documented overdose risk.

What does tianeptine withdrawal feel like?

Tianeptine withdrawal resembles opioid withdrawal in profile: anxiety, muscle aches, agitation, sweating, gastrointestinal cramping, insomnia, and powerful drug craving. Because many users escalate to very high doses, withdrawal can be severe. Medical supervision is strongly advised; buprenorphine has been used to manage tianeptine withdrawal given its opioid mechanism.

What is ‘Neptune’s Fix’ or ‘ZaZa’?

Neptune’s Fix, ZaZa, and similar products are brand names under which tianeptine has been sold as a dietary supplement at gas stations, smoke shops, and online retailers. They typically contain tianeptine sodium or tianeptine sulfate marketed for “wellbeing” or “mood support.” The sulfate form is absorbed more slowly than the sodium form, moderating the rush but not eliminating dependence risk.

How does tianeptine addiction differ from heroin or prescription opioid addiction?

Pharmacologically, tianeptine’s opioid mechanism creates a similar dependence pattern, but the social profile differs: many users started with tianeptine as an over-the-counter mood product rather than a street drug or prescription, and may not identify as having an opioid problem. Treatment, however, follows the same clinical pathway—medically supervised detox, MAT consideration, and behavioral treatment for the underlying drivers of use.